Ledger.Open graph →
SEC Form D · filed August 24, 2020

Clene Nanomedicine, Inc

Offering
$46.2M
Sold
$42.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Shalom Jacobovitz · Salt Lake City, UTDirectorChad Young · Salt Lake City, UTDirectorRob Etherington · Salt Lake City, UTExec · DirectorReed Wilcox · Salt Lake City, UTDirectorAlison Mosca · Salt Lake City, UTDirectorDavid Lisonbee · Salt Lake City, UTDirectorRobert Gay · Salt Lake City, UTDirectorJohn Stevens · Salt Lake City, UTDirectorWilliam Fleming · Fanwood, NJDirectorDoug Kimmel · Fanwood, NJDirectorJoshua P. Tatum · Peachtree Corners, GADirectorJeremy Doo · Wilton, CTDirectorArie Abecassis · White Plains, NYDirectorStephanie C. Arkof · Encino, CADirectorJ. P. Bayliss · Ridgefield, CTExec · DirectorT.J. Stouder · Fanwood, NJDirectorNathaniel Weiss · Cambridge, MADirectorHayfin HF GP LLC · London, United KingdomDirectorMark Tognolini · London, United KingdomDirectorTim Flynn · London, United KingdomDirectorDavid Rushford · London, United KingdomDirectorHoward Rowe · London, United KingdomDirectorHayfin Management Limited · London, United KingdomDirectorYoshiyuki Nakamura · Fletcher, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗